INS and Crush Syndrome: Treatment with Ani significantly enhanced insulin sensitivity in mice with crush syndrome, reflected by reduced serum insulin (P < 0.05), glucose (P < 0.01), and HOMA-IR (P < 0.05), and elevated QUICKI index (P < 0.05).